Trulieve Cannabis Corp. (TCNNF)
OTCMKTS · Delayed Price · Currency is USD
7.71
-0.18 (-2.28%)
At close: Dec 29, 2025
Trulieve Cannabis Revenue
Trulieve Cannabis had revenue of $288.19M in the quarter ending September 30, 2025, with 1.37% growth. This brings the company's revenue in the last twelve months to $1.19B, up 1.44% year-over-year. In the year 2024, Trulieve Cannabis had annual revenue of $1.19B with 5.07% growth.
Revenue (ttm)
1.19B
Revenue Growth
+1.44%
P/S Ratio
1.09
Revenue / Employee
198.20K
Employees
6,000
Market Cap
1.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.19B | 57.30M | 5.07% |
| Dec 31, 2023 | 1.13B | -89.04M | -7.31% |
| Dec 31, 2022 | 1.22B | 286.30M | 30.72% |
| Dec 31, 2021 | 931.93M | 410.40M | 78.69% |
| Dec 31, 2020 | 521.53M | 268.71M | 106.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
Trulieve Cannabis News
- 3 days ago - 3 Marijuana Stocks To Watch In 2026 - MarijuanaStocks
- 6 days ago - President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys? - The Motley Fool
- 7 days ago - President Donald Trump Just Fast-Tracked the Rescheduling of Marijuana, and Pot Stocks Plunged -- Here's the Nefarious Reason Why - The Motley Fool
- 11 days ago - Trulieve Cannabis: Cash-Generative Platform With Schedule III Optionality - Seeking Alpha
- 11 days ago - Trulieve Applauds Trump Administration Decision To Reschedule Marijuana to Schedule III - PRNewsWire
- 12 days ago - Pot stocks pop on Schedule 3 hopes: Tilray Brands, Trulieve Cannabis, Cresco Labs: How high will they go? - Fast Company
- 12 days ago - Trulieve Announces Closing of US$140 Million Private Placement of 10.5% Senior Secured Notes - PRNewsWire
- 13 days ago - Why Trulieve Cannabis Skyrocketed 14.1% Today - The Motley Fool